Hossein Haji Ali Afzali

• Appointments

  Date	Position	Institution name
  2017 - ongoing	Senior Lecturer (Health Economics)	University of Adelaide, Adelaide
  2012 - 2016	Senior Research Fellow (Health Economics)	University of Adelaide
  2009 - 2011	Research Fellow (Health Economics)	University of Adelaide
  2007 - 2009	Senior Research Officer	University of Adelaide
  2000 - 2002	Head (Abourayhan Medical Centre)	The Iranian Social Security Organization
  1995 - 2000	General Practitioner	The Iranian Social Security Organization

• Education

  Date	Institution name	Country	Title
  2004 - 2007	University of Adelaide	Australia	PhD in Health Economics
  2003 - 2004	University of Adelaide	Australia	Graduate Diploma in Public Health
  1987 - 1995	University of Tehran	Iran	Doctor of Medicine (MD)

• Journals

  Year	Citation
  2024	Strube, T., Lambrakis, K., George, K., Lehman, S., Ali Afzali, H. H., & Chew, D. P. (2024). Could Computed Tomography Coronary Angiography Replace Invasive Coronary Angiography as a First-Line Diagnostic Investigation in Suspected Acute Coronary Syndromes? A Decision-Analytic Model. Heart Lung and Circulation, 33(3), 342-349. DOI Scopus1
  2023	Best, K. P., Gould, J. F., Makrides, M., Sullivan, T., Cheong, J., Zhou, S. J., . . . Green, T. (2023). Prenatal iodine supplementation and early childhood neurodevelopment: the PoppiE trial - study protocol for a multicentre randomised controlled trial. BMJ Open, 13(5), e071359-1-e071359-8. DOI Scopus2 Europe PMC2
  2023	Pincombe, A., Afzali, H. H. A., Visvanathan, R., & Karnon, J. (2023). Development and validation of an individual-based state-transition model for the prediction of frailty and frailty-related events. PloS one, 18(8), 1-18. DOI Scopus1
  2023	Merlin, T., Street, J., Carter, D., & Haji Ali Afzali, H. (2023). Challenges in the Evaluation of Emerging Highly Specialised Technologies: Is There a Role for Living HTA?. Applied Health Economics and Health Policy, 21(6), 823-830. DOI Scopus3
  2023	Edney, L. C., Haji Ali Afzali, H., Visvanathan, R., Toson, B., & Karnon, J. (2023). An exploration of healthcare use in older people waiting for and receiving Australian community-based aged care services. Geriatrics and Gerontology International, 23(12), 899-905. DOI
  2023	Hossain, S., Moeller, H., Sharpe, P., Campbell, M., Kimlin, R., Porykali, B., . . . Ryder, C. (2023). Characterising the Aboriginal and Torres Strait Islander patient journey after a serious road traffic injury and barriers to access to compensation: a protocol. Injury Prevention, 30(1), 75-80. DOI
  2022	Karnon, J., Partington, A., & Afzali, H. (2022). Strategies for Avoiding Neglect of Opportunity Costs by Decision-Makers. Applied Health Economics and Health Policy, 20(1), 9-11. DOI
  2022	Karnon, J., Afzali, H. H. A., & Bonevski, B. (2022). An Economic Evaluation of Government-Funded COVID-19 Testing in Australia. Applied Health Economics and Health Policy, 20(5), 681-691. DOI Scopus1
  2021	Haji Ali Afzali, H., Street, J., Merlin, T., & Karnon, J. (2021). The representation of public values in health technology assessment to inform funding decisions: The case of Australia's national funding bodies. International Journal of Technology Assessment in Health Care, 37(1), 1-4. DOI Scopus5 WoS3 Europe PMC2
  2021	Jadczak, A. D., Robson, L., Cooper, T., Bell, J. S., & Visvanathan, R. (2021). The Frailty In Residential Sector over Time (FIRST) study: methods and baseline cohort description. BMC Geriatrics, 21(1), 99-1-99-12. DOI Scopus24 WoS15 Europe PMC11
  2021	Haji Ali Afzali, H., & Karnon, J. (2021). Expediting Patient Access to New Health Technologies: Role of Disease-Specific Reference Models. Value in Health, 24(6), 755-758. DOI Scopus4 WoS1 Europe PMC2
  2021	Wilkin, R., Clouston, H., Coe, P., Duarte, R., Stott, M., Pockney, P., . . . Waite, K. (2021). An international pragmatic randomized controlled trial to compare a single-use negative-pressure dressing versus the surgeon’s preference of dressing to reduce the incidence of surgical site infection following emergency laparotomy: the SUNRRISE trial protocol. Colorectal Disease, 23(4), 989-1000. DOI Scopus5 WoS5 Europe PMC1
  2019	Marshall, H., McMillan, M., Wang, B., Booy, R., Afzali, H., Buttery, J., . . . Barton, B. (2019). AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults.. BMJ Open, 9(12), e032583. DOI Scopus4 WoS3 Europe PMC3
  2019	Edney, L., Haji Ali Afzali, H., & Karnon, J. (2019). Are the benefits of new health services greater than their opportunity costs?. Australian Health Review, 43(5), 508-510. DOI Scopus2 WoS3
  2019	Wang, B., Santoreneos, R., Giles, L., Haji Ali Afzali, H., & Marshall, H. (2019). Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine, 37(21), 2768-2782. DOI Scopus134 WoS102 Europe PMC74
  2019	Haji Ali Afzali, H., Bojke, L., & Karnon, J. (2019). Improving decision-making processes in health: is it time for (disease-specific) reference models?. Applied Health Economics and Health Policy, 18(1), 1-4. DOI Scopus5 WoS4 Europe PMC2
  2019	Afzali, H. H. A., Karnon, J., Theou, O., Beilby, J., Cesari, M., & Visvanathan, R. (2019). Structuring a conceptual model for cost effectiveness analysis of frailty interventions. PLoS ONE, 14(9), e0222049. DOI Scopus11 WoS8 Europe PMC8
  2019	Wang, B., Hajiali Afzali, H., Giles, L., & Marshall, H. (2019). Lifetime costs of invasive meningococcal disease: a Markov model approach. Vaccine, 37(46), 6885-6893. DOI Scopus6 WoS2 Europe PMC6
  2018	Kim, C., Kim, J., Marshall, R., & Afzali, H. (2018). Stakeholder influence, institutional duality, and CSR involvement of MNC subsidiaries. Journal of Business Research, 91, 40-47. DOI Scopus64
  2018	Edney, L., Haji Ali Afzali, H., Cheng, T., & Karnon, J. (2018). Estimating the reference incremental cost-effectiveness ratio for the Australian health system. PharmacoEconomics, 36(2), 239-252. DOI Scopus162 WoS130 Europe PMC82
  2018	Karnon, J., Edney, L., & Afzali, H. (2018). The political economy of the assessment of value of new health technologies. Journal of Health Services Research and Policy, 23(2), 116-122. DOI Scopus5 WoS4 Europe PMC1
  2018	Lambert, R., Carter, D. A., Burgess, N., & Hajiali Afzali, H. (2018). The development of funding recommendations for health technologies at the state level: a South Australian case study. The International Journal of Health Planning and Management, 33(4), 806-822. DOI Scopus2 WoS1
  2018	Edney, L., Haji Ali Afzali, H., Cheng, T., & Karnon, J. (2018). Mortality reductions from marginal increases in public spending on health. Health Policy, 122(8), 892-899. DOI Scopus17 WoS13 Europe PMC7
  2018	Wang, B., Santoreneos, R., Afzali, H., Giles, L., & Marshall, H. (2018). Costs of invasive meningococcal disease: a global systematic review. PharmacoEconomics, 36(10), 1201-1222. DOI Scopus22 WoS16 Europe PMC16
  2018	Haji Ali Afzali, H., Bojke, L., & Karnon, J. (2018). Model structuring for economic evaluations of new health technologies. PharmacoEconomics, 36(11), 1309-1319. DOI Scopus14 WoS12 Europe PMC8
  2017	Karnon, J., Afzali, H., Putro, G., Thant, P., Dompok, A., Cox, I., . . . Cameron, I. (2017). A cost-effectiveness model for frail older persons: development and application to a physiotherapy-based intervention. Applied Health Economics and Health Policy, 15(5), 635-645. DOI Scopus9 WoS8 Europe PMC4
  2017	Gray, J., Hoon, E., Hajiali Afzali, H., Spooner, C., Harris, M. F., & Karnon, J. (2017). Is the Counterweight Program a feasible and acceptable option for structured weight management delivered by practice nurses in Australia? A mixed methods study. Australian Journal of Primary Health, 23(4), 348-363. DOI Scopus4 WoS3 Europe PMC1
  2017	Wang, B., Chen, G., Ratcliffe, J., Afzali, H., Giles, L., & Marshall, H. (2017). Adolescent values for immunisation programs in Australia: a discrete choice experiment. PLoS ONE, 12(7), e0181073-1-e0181073-14. DOI Scopus20 WoS16 Europe PMC16
  2017	Karnon, J., & Afzali, H. H. (2017). Predictive Validation and the Re-Analysis of Cost-Effectiveness: Do We Dare to Tread?. PharmacoEconomics, 35(11), 1111-1112. DOI Scopus1 WoS1 Europe PMC1
  2016	Wang, B., Giles, L., Afzali, H., Clarke, M., Ratcliffe, J., Chen, G., & Marshall, H. (2016). Adolescent confidence in immunisation: assessing and comparing attitudes of adolescents and adults. Vaccine, 34(46), 5595-5603. DOI Scopus13 WoS12 Europe PMC9
  2016	Carter, D. A., Vogan, A., & Haji Ali Afzali, H. (2016). Governments need better guidance to maximise value for money: the case of Australia’s Pharmaceutical Benefits Advisory Committee. Applied Health Economics and Health Policy, 14(4), 401-407. DOI Scopus15 WoS11 Europe PMC7
  2016	Haji Ali Afzali, H., Karnon, J., & Sculpher, M. (2016). Should the Lambda (λ) Remain Silent?. PharmacoEconomics, 34(4), 323-329. DOI Scopus10 WoS7 Europe PMC5
  2015	Haji Ali Afzali, H., & Karnon, J. (2015). Exploring structural uncertainty in model-based economic evaluations. PharmacoEconomics, 33(5), 435-443. DOI Scopus24 WoS17 Europe PMC11
  2015	Frederix, G. W. J., Haji Ali Afzali, H., Dasbach, E. J., & Ward, R. L. (2015). Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions. PharmacoEconomics, 33(8), 777-781. DOI Scopus9 WoS7 Europe PMC5
  2014	Karnon, J., & Haji Ali Afzali, H. (2014). When to use Discrete Event Simulation (DES) for the economic evaluation of health technologies? A review and critique of the costs and benefits of DES. PharmacoEconomics, 32(6), 547-558. DOI Scopus60 WoS44 Europe PMC31
  2014	Afzali, H., Karnon, J., Beilby, J., Gray, J., Holton, C., & Banham, D. (2014). Practice nurse involvement in general practice clinical care: policy and funding issues need resolution. Australian Health Review, 38(3), 301-305. DOI Scopus19 WoS17 Europe PMC10
  2014	Wang, B., Clarke, M., Thomas, N., Howell, S., Afzali, H., & Marshall, H. (2014). The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children. Pediatric Infectious Disease Journal, 33(3), 316-318. DOI Scopus21 WoS24 Europe PMC12
  2014	Gray, J., Haji Ali Afzali, H., Beilby, J., Holton, C., Banham, D., & Karnon, J. (2014). Practice nurse involvement in primary care depression management: an observational cost-effectiveness analysis. BMC Family Practice, 15(10), 10-1-10-11. DOI Scopus4 WoS4 Europe PMC1
  2014	Wang, B., Haji Ali Afzali, H., & Marshall, H. (2014). The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children. Vaccine, 32(37), 4791-4798. DOI Scopus31 WoS23 Europe PMC19
  2014	Wang, B., Clarke, M., Hajiali Afzali, H., & Marshall, H. (2014). Community, parental and adolescent awareness and knowledge of meningococcal disease. Vaccine, 32(18), 2042-2049. DOI Scopus22 WoS18 Europe PMC19
  2013	Hajiali Afzali, H., Gray, J., Beilby, J., Holton, C., & Karnon, J. (2013). A model-based economic evaluation of improved primary care management of patients with type 2 diabetes in Australia. Applied Health Economics and Health Policy, 11(6), 661-670. DOI Scopus6 WoS7 Europe PMC4
  2013	Carter, D., Hajiali Afzali, H., Street, J., Bessen, T., & Neuhaus, S. (2013). Melanoma follow up: time to generate the evidence. Australian Health Review, 37(4), 501-503. DOI WoS1 Europe PMC1
  2013	Hajiali Afzali, H., Gray, J., Beilby, J., Holton, C., Banham, D., & Karnon, J. (2013). A risk-adjusted economic evaluation of alternative models of involvement of practice nurses in management of type 2 diabetes. Diabetic Medicine, 30(7), 855-863. DOI Scopus9 WoS9 Europe PMC7
  2013	Hajiali Afzali, H., Gray, J., & Karnon, J. (2013). Model performance evaluation (validation and calibration) in model-based studies of therapeutic interventions for cardiovascular diseases: A review and suggested reporting framework. Applied Health Economics and Health Policy, 11(2), 85-93. DOI Scopus18 WoS17 Europe PMC15
  2013	Karnon, J., Hajiali Afzali, H., Gray, J., Holton, C., Banham, D., & Beilby, J. (2013). A risk adjusted cost-effectiveness analysis of alternative models of nurse involvement in obesity management in primary care. Obesity, 21(3), 472-479. DOI Scopus11 WoS10 Europe PMC8
  2013	Hajiali Afzali, H., Karnon, J., & Merlin, T. (2013). Improving the accuracy and comparability of model-based economic evaluations of health technologies for reimbursement decisions: a methodological framework for the development of reference models. Medical Decision Making, 33(3), 325-332. DOI Scopus30 WoS26 Europe PMC22
  2012	Hajiali Afzali, H., Karnon, J., Gray, J., & Beilby, J. (2012). A model-based evaluation of collaborative care in management of patients with type 2 diabetes in Australia: an initial report. Australian Health Review, 36(3), 258-263. DOI Scopus3 WoS4 Europe PMC3
  2012	Hajiali Afzali, H., Karnon, J., & Gray, J. (2012). A critical review of model-based economic studies of depression: modelling techniques, model structure and data sources. Pharmacoeconomics, 30(6), 461-482. DOI Scopus27 WoS20 Europe PMC14
  2012	Hajiali Afzali, H., Karnon, J., & Gray, J. (2012). A proposed model for economic evaluations of major depressive disorder. European Journal of Health Economics, 13(4), 501-510. DOI Scopus15 WoS13 Europe PMC10
  2012	Hajiali Afzali, H., Karnon, J., Gray, J., & Beilby, J. (2012). Evaluation of collaborative models of care in the management of patients with depression: protocol and progress. Mental Health in Family Medicine, 9(2), 91-97. Scopus1
  2011	Hajiali Afzali, H., Moss, J., & Mahmood, M. (2011). Exploring health professionals' perspectives on factors affecting Iranian hospital efficiency and suggestions for improvement. International Journal of Health Planning and Management, 26(1), E17-E29. DOI Scopus8 WoS6 Europe PMC6
  2011	Haji Ali Afzali, H., & Karnon, J. (2011). Addressing the challenge for well informed and consistent reimbursement decisions: The case for reference models. PharmacoEconomics, 29(10), 823-825. DOI Scopus17 WoS13 Europe PMC14
  2009	Hajiali Afzali, H., Moss, J., & Mahmood, M. (2009). A conceptual framework for selecting the most appropriate variables for measuring hospital efficiency with a focus on Iranian public hospitals. Health Services Management Research, 22(2), 81-91. DOI Scopus20 WoS14 Europe PMC15
  2007	Hajiali Afzali, H., Moss, J., & Mahmood, M. (2007). Efficiency measurement for hospitals owned by the Iranian Social Security organisation. Journal of Medical Systems, 31(3), 166-172. DOI Scopus41 WoS28 Europe PMC18
  -	Wang, B., Santoreneos, R., Giles, L., Afzali, H. H. A., & Marshall, H. (n.d.). Case Fatality Rates of Invasive Meningococcal Disease by Serogroup and Age: A Global Systematic Review and Meta-Analysis. SSRN Electronic Journal. DOI

• Book Chapters

  Year	Citation
  2014	Haji Ali Afzali, H., & Karnon, J. (2014). Specification and implementation of decision analytic model structures for the economic evaluation of health care technologies. In A. J. Culyer (Ed.), Encyclopedia of Health Economics (1st ed., pp. 340-347). Elsevier. DOI Scopus6

• Conference Papers

  Year	Citation
  2017	Edney, L. C., Afzali, H. A. H., Cheng, T., & Kamon, J. (2017). ESTIMATING THE REFERENCE ICER FOR AUSTRALIA AND PUBLIC PERCEPTIONS TOWARD ITS USE. In VALUE IN HEALTH Vol. 20 (pp. A685). ELSEVIER SCIENCE INC. DOI

• Conference Items

  Year	Citation
  2015	Gray, J. P., Hajiali Afzali, H., Harris, M., Spooner, C., & Karnon, J. (2015). Countering weight gain in general practice [Plenary presentation]. Poster session presented at the meeting of COMPaRE-PHC forum on obesity prevention and management in primary health care. Sydney, Australia.
  2015	Gray, J. P., Hajiali Afzali, H., Harris, M., Spooner, C., Hunter-Riviere, V., Ross, H., . . . Karnon, J. (2015). Weight management in general practice: Piloting the Counterweight Program in Australia. Poster session presented at the meeting of Population Health Congress. Hobart, Australia.
  2015	Gray, J. P., Hunter-Riviere, V., Hajiali Afzali, H., Harris, M., Spooner, C., Ross, H., . . . Karnon, J. (2015). Engaging practice nurses in obesity management – a clinical academic partnership to pilot the Counterweight Program [Presentation]. Poster session presented at the meeting of PHC Research Conference. Adelaide, Australia.
  2015	Hajiali Afzali, H., Karnon, J., & Sculpher, M. (2015). Should the lambda remain silent?. Poster session presented at the meeting of 12th Annual Conference of Health Technology Assessment International (HTAi).. Oslo: Norway.
  2015	Hajiali Afzali, H. (2015). Structural uncertainty in decision making. Poster session presented at the meeting of Centre for Health Economics. Monash University. Melbourne-Australia.
  2014	Hajiali Afzali, H. (2014). Improving the quality of decisions around the public funding of new health technologies: The value of disease-specific (reference) models. Poster session presented at the meeting of 11th Annual Conference of Health Technology Assessment International (HTAi).. Washington DC: USA.
  2013	• Haji Ali Afzali, H., Karnon, J., Merlin, T., & Hajiali Afzali, H. (2013). Improving the accuracy and comparability of model-based economic evaluations of health technologies for reimbursement decisions: a methodological framework for the development of reference models.. Poster session presented at the meeting of the 10th Annual Health Technology Assessment international (HTAi) Conference. Seoul, South Korea.
  2011	Gray, J. P., Hajiali Afzali, H., & Karnon, J. (2011). A model based evaluation of primary care based initiatives in the management of patients with obesity in Australia [Plenary presentation]. Poster session presented at the meeting of Tri State PHCRED Annual Conference. Adelaide, Australia.

• Preprint

  Year	Citation
  2022	Karnon, J., Afzali, H., & Bonevski, B. (2022). Should rapid antigen tests be government funded in Australia? An economic evaluation. DOI

Teaching

2014- Ongoing           Course coordinator: PUB HLTH 7082 Health Economics (face to face) (Core course: Master of Health Economics and Policy)

2015- Ongoing           Course coordinator: PUB HLTH 7082OL Health Economics (fully online) (Core course: Master of Health Economics and Policy

2016-Ongoing            Course coordinator: HLTH SC 2012 Hacking Health: Core course for BHlthMedSc (Advanced)      

2016-Ongoing            Module (economic evaluation) coordinator: PUB HLTH 7091 Knowing What Works - Evaluation for Public Health (Core course: Master of Public Health)

2014-Ongoing            Course coordinator: Health economics (for third-year medical students) as part of Medical, Personal and Professional Development III (MPPD III)

2010- Ongoing           Lecturer: PubHlth 7082 Health Economic Evaluation and Decision Making  (Core course: Master of Health Economics and Policy)

2012- Ongoing           Lecturer: PubHlth 7147 (Health Technology Assessment)

• Past Higher Degree by Research Supervision (University of Adelaide)

  Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
  2014 - 2019	Co-Supervisor	Improving Adolescent Health Through Immunisation: A Case Study - Invasive Meningococcal Disease	Doctor of Philosophy	Doctorate	Full Time	Dr Bing Wang
  2012 - 2014	Co-Supervisor	Clinical outcomes, costs, knowledge and awareness of invasive meningococcal disease (IMD) in South Australia	Master of Philosophy (Public Health)	Master	Full Time	Dr Bing Wang

• Consulting/Advisories

  Date	Institution	Department	Organisation Type	Country
  2015 - ongoing	-	-	-	-
  2012 - ongoing	Adelaide Health Technology Assessment (AHTA)	-	-	Australia
  2012 - 2014	Australian Catholic University	-	-	Australia

• Editorial Boards

  Date	Role	Editorial Board Name	Institution	Country
  2014 - ongoing	Board Member	Applied Health Economics and Health Policy	-	Australia

• Email: hossein.afzali@adelaide.edu.au